Xilonix

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xilonix, covering 2021-03-01 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum [Phase 2]